Isosorbide mononitrate ER 30/60/120 mg tabs — $0 with Membership
Isosorbide mononitrate ER 30/60/120 mg tabs has an active canonical formulary match. No-additional-cost pricing is subject to its listed supply, quantity, fill, and fulfillment limits.
Isosorbide mononitrate ER 30/60/120 mg tabs Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | $0 with membership |
| Typical Retail | $134.00 |
Free with membership subject to the listed formulary limits.
About Isosorbide mononitrate ER 30/60/120 mg tabs
Isosorbide mononitrate ER 30/60/120 mg tabs is a prescription medication. Ask your doctor if Isosorbide mononitrate ER 30/60/120 mg tabs is right for you.
Other strengths and forms of Isosorbide Mononitrate
Conditions Treated with Isosorbide mononitrate ER 30/60/120 mg tabs
How to Check Isosorbide mononitrate ER 30/60/120 mg tabs Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Isosorbide mononitrate ER 30/60/120 mg tabs at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Related medications
Other medications associated with the same conditions in this catalog.
Also listed for Coronary Artery Disease/Angina
What Isosorbide mononitrate ER 30/60/120 mg tabs is approved for (FDA label)
Isosorbide mononitrate extended-release tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.
Source: Read the full FDA label on DailyMed. Label effective date: July 31, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Isosorbide mononitrate ER 30/60/120 mg tabs (FDA label)
The table below shows the frequencies of the adverse events that occurred in >5% of the subjects in three placebo-controlled North American studies, in which patients in the active treatment arm received 30 mg, 60 mg, 120 mg, or 240 mg of isosorbide mononitrate extended-release tablets once daily. In parentheses, the same table shows the frequencies with which these adverse events were associated with the discontinuation of treatment. Overall, 8% of the patients who received 30 mg, 60 mg, 120 mg, or 240 mg of isosorbide mononitrate in the three placebo-controlled North American studies discontinued treatment because of adverse events. Most of these discontinued because of headache. Dizziness was rarely associated with withdrawal from these studies.
Source: FDA prescribing information (DailyMed). Set ID: d01d4f0f-5164-4ea3-b772-72b97961c6fb. SPL document ID: 57e8068b-c8e0-5eb7-e063-6394a90a3b14. Label effective date: July 31, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Isosorbide mononitrate ER 30/60/120 mg tabs (FDA label)
Isosorbide mononitrate extended-release tablets are contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.
Source: FDA prescribing information (DailyMed). Set ID: d01d4f0f-5164-4ea3-b772-72b97961c6fb. SPL document ID: 57e8068b-c8e0-5eb7-e063-6394a90a3b14. Label effective date: July 31, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.